StockData
LeMaitre Vascular Inc logo

LeMaitre Vascular Inc (LMAT) stock

LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$75.58−0.52 (-0.68%)

Close on Nov 18, 2026Market cap $1.73BP/E 26.5Yield 1.06%

LeMaitre Vascular operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

LeMaitre Vascular's operating income for the twelve months ending Jun 30, 2026 was $77.32M, up 41.2% year over year. For fiscal 2025 it was $67.91M, up 30.0% from the year before. Over ten years it grew 19.4% a year on average. The highest annual figure on record is $67.91M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$67.91M+30.0%
FY2024Dec 31, 2024$52.26M+42.3%
FY2023Dec 31, 2023$36.71M+36.8%
FY2022Dec 31, 2022$26.83M-26.3%
FY2021Dec 31, 2021$36.43M+26.5%
FY2020Dec 31, 2020$28.79M+35.9%
FY2019Dec 31, 2019$21.18M-24.9%
FY2018Dec 31, 2018$28.21M+33.7%
FY2017Dec 31, 2017$21.10M+29.2%
FY2016Dec 31, 2016$16.34M+41.9%
FY2015Dec 31, 2015$11.51M+81.6%
FY2014Dec 31, 2014$6.34M+40.3%
FY2013Dec 31, 2013$4.52M+6.6%
FY2012Dec 31, 2012$4.24M+14.9%
FY2011Dec 31, 2011$3.69M-8.1%
FY2010Dec 31, 2010$4.02M+106.0%
FY2009Dec 31, 2009$1.95M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$20.40M+26.4%
Q1 FY2026Mar 31, 2026$17.78M+40.8%
Q4 FY2025Dec 31, 2025$18.83M+46.5%
Q3 FY2025Sep 30, 2025$20.31M+54.5%
Q2 FY2025Jun 30, 2025$16.14M+12.3%
Q1 FY2025Mar 31, 2025$12.63M+6.3%
Q4 FY2024Dec 31, 2024$12.85M+25.9%
Q3 FY2024Sep 30, 2024$13.15M+43.2%
Q2 FY2024Jun 30, 2024$14.38M+52.1%
Q1 FY2024Mar 31, 2024$11.87M+50.8%
Q4 FY2023Dec 31, 2023$10.21M+46.5%
Q3 FY2023Sep 30, 2023$9.18M+49.3%
Q2 FY2023Jun 30, 2023$9.45M+63.4%
Q1 FY2023Mar 31, 2023$7.87M-0.7%
Q4 FY2022Dec 31, 2022$6.97M-16.1%
Q3 FY2022Sep 30, 2022$6.15M-32.2%
Q2 FY2022Jun 30, 2022$5.78M-47.9%
Q1 FY2022Mar 31, 2022$7.93M-0.2%
Q4 FY2021Dec 31, 2021$8.30M-13.0%
Q3 FY2021Sep 30, 2021$9.07M-9.4%
Q2 FY2021Jun 30, 2021$11.11M+128.0%
Q1 FY2021Mar 31, 2021$7.95M+82.5%
Q4 FY2020Dec 31, 2020$9.55M+93.7%
Q3 FY2020Sep 30, 2020$10.02M+69.7%
Q2 FY2020Jun 30, 2020$4.87M-17.6%
Q1 FY2020Mar 31, 2020$4.35M-1.8%
Q4 FY2019Dec 31, 2019$4.93M-31.5%
Q3 FY2019Sep 30, 2019$5.91M+28.0%
Q2 FY2019Jun 30, 2019$5.92M-48.7%
Q1 FY2019Mar 31, 2019$4.44M-8.8%
Q4 FY2018Dec 31, 2018$7.19M+13.8%
Q3 FY2018Sep 30, 2018$4.61M-8.7%
Q2 FY2018Jun 30, 2018$11.54M+108.5%
Q1 FY2018Mar 31, 2018$4.86M+16.0%
Q4 FY2017Dec 31, 2017$6.32M+61.7%
Q3 FY2017Sep 30, 2017$5.05M-5.4%
Q2 FY2017Jun 30, 2017$5.54M–
Q1 FY2017Mar 31, 2017$4.19M–
Q4 FY2016Dec 31, 2016$3.91M–
Q3 FY2016Sep 30, 2016$5.34M–

More LeMaitre Vascular figures

See a number that looks wrong?